Showing 5661-5670 of 5956 results for "".
- Multicolor Holography Technology Could Enable Extremely Compact 3D Displayshttps://modernod.com/news/multicolor-holography-technology-could-enable-extremely-compact-3d-displays/2479595/Researchers have developed a new approach to multicolor holography that could be used to make 3D color displays for augmented reality glasses, smartphones, or heads-up displays without any bulky optical components. In Optica, researchers from Duke University, describe how they encod
- Nicox Announces FDA Acceptance of Investigational NDA for NCX 4251 Phase 2 Trial in Blepharitishttps://modernod.com/news/nicox-announces-fda-acceptance-of-investigational-nda-for-ncx-4251-phase-2-trial-in-blepharitis/2479597/Nicox SA announced that the FDA has completed its review of the company’s investigational new drug (IND) application for NCX 4251, a novel patented ophthalmic suspension of fluticasone propionate nanocrystals, being developed as the fi
- EyePoint Pharmaceuticals Appoints David Guyer, MD, to Board of Directorshttps://modernod.com/news/eyepoint-pharmaceuticals-appoints-david-guyer-md-to-board-of-directors/2479602/EyePoint Pharmaceuticals announced the appointment of David Guyer, MD, to the company’s Board of Directors. He will also serve on the company’s Science Committee. Dr. Guyer has led several public and private biotechnology companies focused on ocular diseases, and has held leadership positi
- FDA Commissioner Gottlieb Announces Efforts to Improve Assessment of REMS Programshttps://modernod.com/news/fda-commissioner-gottlieb-announces-efforts-to-improve-assessment-of-rems-programs/2479604/In an FDA statement, Commissioner Scott Gottlieb, MD, announced efforts to improve the quality of the information used to assess the effectiveness of Risk Evaluation and Mitigation Strategy (REMS) programs in supporting the safe use of medications. In making decisions about whether the ben
- Joe Garibaldi Appointed Vice President of US Sales at Optovuehttps://modernod.com/news/joe-garibaldi-appointed-vice-president-of-us-sales-at-optovue/2476172/Joe Garibaldi has been appointed to vice president of US Sales at Optovue, where he will continue to lead the US sales force as well as identify new strategic partnering opportunities to grow the company’s US product portfolio. Garibaldi joined Optovue in 2009 as a territory manager and he
- Lifestyle Choices May Help Glaucoma Patients Preserve Eyesighthttps://modernod.com/news/lifestyle-choices-may-help-glaucoma-patients-preserve-eyesight/2476174/Glaucoma is one of the leading causes of vision loss, aff
- Compulink Showcases SMART Ophthalmology EHR Solution at Hawaiian Eye 2019https://modernod.com/news/compulink-showcases-smart-ophthalmology-ehr-solution-at-hawaiian-eye-2019/2476177/Compulink Healthcare Solutions will demonstrate its ophthalmology-specific system, Ophthalmology Advantage at Hawaiian Eye. Ophthalmology Advantage uses AI technology and real-time data from the clinic to completely automate tasks such as billing, along with eliminating steps to improve pa
- DORC Unveils Enhancements to the EVA Phacovitrectomy Systemhttps://modernod.com/news/dorc-unveils-enhancements-to-the-eva-phacovitrectomy-system/2476178/DORC has announced the launch several enhancements to its EVA surgical system aimed at delivering both operating room efficiency and surgical performance. The enhancements include a new EVA footswitch that been completely redesigned. Control of the EVA endolaser is now integrated into the
- Burnout Rises Above 50% in Some Specialties, New Survey Showshttps://modernod.com/news/burnout-rises-above-50-in-some-specialties-new-survey-shows/2476179/Responses to a new Medscape survey indicate that 44% of physicians meet the criteria for burnout, up from 42% in last year’s report. In addition, 11% are colloquially depressed (feeling down or sad), and 4% are clinically depressed, according to the
- Cyclosporine Emulsion Promising in Vernal Keratoconjunctivitishttps://modernod.com/news/cyclosporine-emulsion-promising-in-vernal-keratoconjunctivitis/2476182/Cyclosporine A cationic emulsion (CsA CE) appears more effective than vehicle alone in treating pediatric patients with vernal keratoconjunctivitis, according to a study funded by the developer, Santen, as reported by Reuters. In a